Published in J Gen Virol on May 01, 1995
Principles and applications of methods for DNA-based typing of microbial organisms. J Clin Microbiol (1999) 5.88
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Genetic methods for assessing antimicrobial resistance. Antimicrob Agents Chemother (1999) 1.60
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol (2000) 1.47
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol (1998) 1.46
Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J Clin Microbiol (1997) 1.43
Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay. J Clin Microbiol (1996) 1.41
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol (2000) 1.32
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31
Simplified hepatitis C virus genotyping by heteroduplex mobility analysis. J Clin Microbiol (2000) 1.31
Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region. J Clin Microbiol (1997) 1.25
Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo. J Virol (2006) 1.23
Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis. J Clin Microbiol (1997) 1.16
Investigating the origin and spread of hepatitis C virus genotype 5a. J Virol (2006) 1.16
Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol (1996) 1.14
Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol (1996) 1.14
Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut (1996) 1.08
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol (1997) 1.07
Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study. J Clin Microbiol (2000) 1.06
Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol (1996) 1.03
Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol (1997) 1.02
Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. J Clin Microbiol (2007) 1.00
Determination of genotypes of hepatitis C virus in Venezuela by restriction fragment length polymorphism. J Clin Microbiol (1997) 0.97
Genotypic distribution of hepatitis C virus in different regions of Thailand. J Clin Microbiol (1997) 0.95
Computer-aided identification of polymorphism sets diagnostic for groups of bacterial and viral genetic variants. BMC Bioinformatics (2007) 0.95
Matrix-assisted laser desorption ionization-time of flight (mass spectrometry) for hepatitis C virus genotyping. J Clin Microbiol (2005) 0.94
Genetic diversity of near genome-wide hepatitis C virus sequences during chronic infection: evidence for protein structural conservation over time. PLoS One (2011) 0.93
Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C. Can J Gastroenterol (2010) 0.93
Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection. Int J Circumpolar Health (2012) 0.92
Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J (2005) 0.92
Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes. J Clin Microbiol (2006) 0.91
Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China. J Clin Microbiol (1995) 0.91
High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong. Eur J Epidemiol (1998) 0.91
Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients. J Clin Microbiol (1998) 0.90
Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol (2007) 0.89
cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C. Dig Dis Sci (1997) 0.88
Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region. PLoS One (2010) 0.88
Hepatitis C virus infection in blood donors from the state of Puebla, Mexico. Virol J (2010) 0.87
Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay. J Clin Microbiol (1997) 0.87
Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes. J Clin Microbiol (2001) 0.87
Hepatitis C virus heteroduplex tracking assay for genotype determination reveals diverging genotype 2 isolates in Italian hemodialysis patients. J Clin Microbiol (1998) 0.86
Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains. J Clin Microbiol (2005) 0.86
Evaluation of a new serotyping assay for detection of anti-hepatitis C virus type-specific antibodies in serum samples. J Clin Microbiol (2003) 0.85
Phylogenetic analysis of previously nontypeable hepatitis C virus isolates from Argentina. J Clin Microbiol (2006) 0.84
Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes. J Clin Microbiol (2006) 0.84
Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes. J Virol (2008) 0.84
Hepatitis C virus infection in infants and children from Argentina. J Clin Microbiol (2004) 0.84
A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame. J Med Virol (2008) 0.83
In vitro detection of dissimilar amounts of hepatitis C virus (HCV) subtype-specific RNA genomes in mixes prepared from sera of persons infected with a single HCV genotype. J Clin Microbiol (2003) 0.83
Hepatitis C virus isolates from Argentina disclose a novel genotype 1-associated restriction pattern. J Clin Microbiol (2004) 0.83
Distribution of HCV genotypes among risk groups in Serbia. Eur J Epidemiol (2000) 0.82
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis. PLoS One (2014) 0.82
Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology (2010) 0.82
Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect (2006) 0.82
Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol (2004) 0.82
Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review. World J Virol (2015) 0.82
Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci (1996) 0.81
Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C. Int J Circumpolar Health (2016) 0.81
Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut (1997) 0.80
Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther (2009) 0.80
Risk factors for infection with different hepatitis C virus genotypes in southern Brazil. ScientificWorldJournal (2012) 0.79
Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience. Clin Mol Hepatol (2012) 0.79
Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region. J Clin Microbiol (1996) 0.78
A new subtype of hepatitis C virus genotype 3: analysis of available evidence. Hepat Mon (2013) 0.78
Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region. Virol J (2007) 0.77
Molecular survey of hepatitis C virus in the touristic city of Mar del Plata, Argentina. PLoS One (2012) 0.77
Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein. J Clin Microbiol (2003) 0.77
Hepatitis C viral heterogeneity based on core gene and an attempt to design small interfering RNA against strains resistant to interferon in rawalpindi, pakistan. Hepat Mon (2012) 0.76
A Novel Structurally Stable Multiepitope Protein for Detection of HCV. Hepat Res Treat (2016) 0.75
Genotyping of hepatitis C virus isolates from Basque Country, Spain. Epidemiol Infect (1996) 0.75
Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10. BMC Microbiol (2016) 0.75
Mistyping of two Slovenian hepatitis C virus subtype 2c isolates as subtype 2b by two 5' noncoding region genotyping methods. J Clin Microbiol (1997) 0.75
Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection. Immunobiology (2010) 0.75
Necessity for reassessment of patients with serogroup 2 hepatitis C virus (HCV) and undetectable serum HCV RNA. J Clin Microbiol (2013) 0.75
Hepatitis C virus genotype 5 in southern belgium: epidemiological characteristics and response to therapy. Dig Dis Sci (2005) 0.75
Molecular characterization of hepatitis c virus in multi-transfused Colombian patients. Virol J (2012) 0.75
Current trends in the treatment of hepatitis C: interventions to avoid adverse effects and increase effectiveness of anti-HCV drugs. EXCLI J (2016) 0.75
Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping. J Clin Pathol (1996) 0.75
Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment. Virol J (2014) 0.75
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80
Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol (1993) 8.47
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature (1995) 6.62
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure (1998) 5.83
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Regulation of flowering time by Arabidopsis photoreceptors. Science (1998) 5.11
Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell (1996) 4.12
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med (2001) 3.84
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Managing patients with lung cancer. New guidelines should improve standards of care. BMJ (1999) 3.65
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient. Proc Natl Acad Sci U S A (1992) 3.58
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Ann Rheum Dis (2007) 3.31
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
The structure of the major cell processes of isolated BHK21 fibroblasts. Exp Cell Res (1969) 3.27
Infection with hepatitis G virus among recipients of plasma products. Lancet (1996) 3.25
Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.16
Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis (2006) 2.97
The occurrence of microvilli during spreading and growth of BHK21-C13 fibroblasts. Exp Cell Res (1970) 2.97
The DNA of a minute virus of mice. J Gen Virol (1969) 2.93
Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.91
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet (1980) 2.90
The Huntington's disease candidate region exhibits many different haplotypes. Nat Genet (1992) 2.84
Antagonistic actions of Arabidopsis cryptochromes and phytochrome B in the regulation of floral induction. Development (1999) 2.76
Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: rate of sequence change and low frequency of inactivating mutations. J Virol (1990) 2.68
Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol (2001) 2.62
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Constitutive expression of the cold-regulated Arabidopsis thaliana COR15a gene affects both chloroplast and protoplast freezing tolerance. Proc Natl Acad Sci U S A (1996) 2.58
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
The origin of hepatitis C virus genotypes. J Gen Virol (1997) 2.26
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
A highly divergent picornavirus in a marine mammal. J Virol (2007) 2.23
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet (1996) 2.20
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1999) 2.19
Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.14
Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol (1997) 2.13
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
Completely diverted tube ileostomy compared with loop ileostomy for protection of low colorectal anastomosis: a pilot study. Colorectal Dis (2014) 2.06
Hypocalcaemia of acute pancreatitis: the effect of hypoalbuminaemia. Curr Med Res Opin (1976) 2.06
Classes and subclasses of rat immunoglobulins: interaction with the complement system and with staphylococcal protein A. Immunochemistry (1978) 2.06
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication. J Virol (1997) 2.00
Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc Natl Acad Sci U S A (1987) 2.00
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature (1997) 1.99
Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol (2005) 1.98
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
The DNAs of three parvoviruses. J Gen Virol (1970) 1.96
The molecular epidemiology of human immunodeficiency virus type 1 in Edinburgh. J Infect Dis (1995) 1.94
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93
Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates. AIDS (1991) 1.93
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
Multistep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent Prog Horm Res (2000) 1.86
The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett (1976) 1.84
Complex patterns of linkage disequilibrium in the Huntington disease region. Am J Hum Genet (1991) 1.84
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS (1989) 1.80
Birefringent filamentous organelle in BHK-21 cells and its possible role in cell spreading and motility. Science (1970) 1.78
The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep (2001) 1.76
Serological responses to infection with three different types of hepatitis C virus. Lancet (1991) 1.73
Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins. J Virol (1974) 1.72
Supramolecular arrays based on dimetal building units. Acc Chem Res (2001) 1.71
Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein. Mol Cell Biol (1988) 1.70
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol (2008) 1.68
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68
Heterosexual transmission of hepatitis C virus. Lancet (1993) 1.65
HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain (1998) 1.65
Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet (1991) 1.63
The Arabidopsis blue light receptor cryptochrome 2 is a nuclear protein regulated by a blue light-dependent post-transcriptional mechanism. Plant J (1999) 1.63